Follow
Su Pan
Su Pan
Houston Methodist
Verified email at houstonmethodist.org
Title
Cited by
Cited by
Year
Cholesterol induces CD8+ T cell exhaustion in the tumor microenvironment
X Ma, E Bi, Y Lu, P Su, C Huang, L Liu, Q Wang, M Yang, MF Kalady, ...
Cell metabolism 30 (1), 143-156. e5, 2019
5372019
CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability
X Ma, L Xiao, L Liu, L Ye, P Su, E Bi, Q Wang, M Yang, J Qian, Q Yi
Cell metabolism 33 (5), 1001-1012. e5, 2021
4022021
Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages
JQQY Pan Su, Qiang Wang, Enguang Bi, Xingzhe Ma, Lintao Liu, Maojie Yang
Cancer Research, 2020
2422020
The transcription factor Bhlhe40 is a switch of inflammatory versus antiinflammatory Th1 cell fate determination
F Yu, S Sharma, D Jankovic, RK Gurram, P Su, G Hu, R Li, S Rieder, ...
Journal of Experimental Medicine 215 (7), 1813-1821, 2018
1132018
Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9
L Liu, E Bi, X Ma, W Xiong, J Qian, L Ye, P Su, Q Wang, L Xiao, M Yang, ...
Nature communications 11 (1), 5902, 2020
622020
Extracellular matrix protein 1 promotes follicular helper T cell differentiation and antibody production
L He, W Gu, M Wang, X Chang, X Sun, Y Zhang, X Lin, C Yan, W Fan, ...
Proceedings of the National Academy of Sciences 115 (34), 8621-8626, 2018
462018
IL-9/STAT3/fatty acid oxidation–mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity
L Xiao, X Ma, L Ye, P Su, W Xiong, E Bi, Q Wang, M Xian, M Yang, J Qian, ...
The Journal of Clinical Investigation 132 (7), 2022
392022
MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma
Q Wang, D Zhao, M Xian, Z Wang, E Bi, P Su, J Qian, X Ma, M Yang, L Liu, ...
Blood, The Journal of the American Society of Hematology 136 (22), 2557-2573, 2020
362020
Novel function of extracellular matrix protein 1 in suppressing Th17 cell development in experimental autoimmune encephalomyelitis
P Su, S Chen, YH Zheng, HY Zhou, CH Yan, F Yu, YG Zhang, L He, ...
The Journal of Immunology 197 (4), 1054-1064, 2016
332016
E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs
E Bi, R Li, LC Bover, H Li, P Su, X Ma, C Huang, Q Wang, L Liu, M Yang, ...
The Journal of clinical investigation 128 (11), 4821-4831, 2018
322018
RARγ activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway
Q Wang, Z Lin, Z Wang, L Ye, M Xian, L Xiao, P Su, E Bi, Y Huang, J Qian, ...
Blood, The Journal of the American Society of Hematology 139 (1), 59-72, 2022
82022
Correction: enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages
P Su, Q Wang, E Bi, X Ma, L Liu, M Yang, J Qian, Q Yi
Cancer Research 82 (5), 945-945, 2022
42022
A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors
P Su, L Xiao, L Ye, Z Wang, W Xiong, Q Wang, X Ma, M Xian, M Yang, ...
Journal of Hematology & Oncology 15 (1), 55, 2022
22022
Development of an Immunotherapeutic Monoclonal Antibody Recognizing DKK1-HLA-A2 Complex to Treat Human Hematologic Malignancies
J Qian, Q Wang, L Liu, E Bi, X Ma, P Su, M Yang, Q Yi
Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019
12019
Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers
J Qian, Q Wang, L Xiao, W Xiong, M Xian, P Su, M Yang, C Zhang, Y Li, ...
Journal for Immunotherapy of Cancer 12 (1), 2024
2024
MIF acting as a chaperone of SOD1 mediates MM cell intrinsic resistance to carfilzomib by modulating ROS-induced mitochondrial dysfunction
Q Wang, P Su, Q Yi
Clinical Lymphoma, Myeloma and Leukemia 19 (10), e140, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–16